[HTML][HTML] Global assessment improves risk stratification for major adverse cardiac events across a wide range of triglyceride levels: insights from the KP REACH study
JR Wagner, JK Fitzpatrick, J Yang, SH Sung… - American Journal of …, 2022 - Elsevier
Objective Patients with risk factors for or established atherosclerotic cardiovascular disease
(ASCVD) remain at high risk for subsequent ischemic events despite statin therapy …
(ASCVD) remain at high risk for subsequent ischemic events despite statin therapy …
Triglyceride levels and residual risk of atherosclerotic cardiovascular disease events and death in adults receiving statin therapy for primary or secondary prevention …
AP Ambrosy, J Yang, SH Sung, AR Allen… - Journal of the …, 2021 - Am Heart Assoc
Background Patients with risk factors or established atherosclerotic cardiovascular disease
remain at high‐risk for ischemic events. Triglyceride levels may play a causal role. Methods …
remain at high‐risk for ischemic events. Triglyceride levels may play a causal role. Methods …
Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations
TS Anderson, LM Wilson, JB Sussman - JAMA Internal Medicine, 2024 - jamanetwork.com
Importance In 2023, the American Heart Association (AHA) developed the Predicting Risk of
Cardiovascular Disease Events (PREVENT) equations to estimate 10-year risk of …
Cardiovascular Disease Events (PREVENT) equations to estimate 10-year risk of …
Statin eligibility for primary prevention of cardiovascular disease according to 2021 European prevention guidelines compared with other international guidelines
MB Mortensen, A Tybjærg-Hansen… - JAMA …, 2022 - jamanetwork.com
Importance For primary prevention of atherosclerotic cardiovascular disease (ASCVD), the
2021 European Society of Cardiology (ESC) guidelines on statin use (hereafter European …
2021 European Society of Cardiology (ESC) guidelines on statin use (hereafter European …
Application of the 2018 cholesterol guideline for secondary prevention in very high-risk patients with atherosclerotic cardiovascular disease in the United States
D Shin, C Bohra, K Kongpakpaisarn - … : Cardiovascular Quality and …, 2019 - Am Heart Assoc
Background: As opposed to the prior cholesterol guideline which did not include low-density
lipoprotein cholesterol (LDL-C) goal for secondary prevention, the 2018 American Heart …
lipoprotein cholesterol (LDL-C) goal for secondary prevention, the 2018 American Heart …
ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study
MB Mortensen, BG Nordestgaard, S Afzal… - European Heart …, 2017 - academic.oup.com
Abstract Aim We compared the 2013 American College of Cardiology/American Heart
Association (ACC/AHA) and the 2016 European Society of Cardiology/European …
Association (ACC/AHA) and the 2016 European Society of Cardiology/European …
Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 American College of Cardiology/American Heart Association …
J Yeboah, TS Polonsky, R Young, RL McClelland… - Circulation, 2015 - Am Heart Assoc
Background—In the general population, the majority of cardiovascular events occur in
people at the low to moderate end of population risk distribution. The 2013 American …
people at the low to moderate end of population risk distribution. The 2013 American …
Burden of atherosclerotic cardiovascular disease risk in persons with elevated Triglyceride levels according to statin use
Background Persons with hypertriglyceridemia (HTG) have greater risks for atherosclerotic
cardiovascular disease (ASCVD), and statin therapy is indicated as initial treatment. Our aim …
cardiovascular disease (ASCVD), and statin therapy is indicated as initial treatment. Our aim …
The Evolving Landscape of Cardiovascular Risk Assessment
Cardiovascular disease (CVD) remains the leading cause of death1 in the US and globally
and risk estimation is a cornerstone approach to guiding CVD prevention. Over the past 2 …
and risk estimation is a cornerstone approach to guiding CVD prevention. Over the past 2 …
2013 ACC/AHA cholesterol guideline and implications for healthy people 2020 cardiovascular disease prevention goals
BM Egan, J Li, K White, DO Fleming… - Journal of the …, 2016 - Am Heart Assoc
Background Healthy People 2020 aim to reduce fatal atherosclerotic cardiovascular disease
(ASCVD) by 20%, which translates into 310 000 fewer events annually assuming …
(ASCVD) by 20%, which translates into 310 000 fewer events annually assuming …
相关搜索
- global assessment triglyceride levels
- risk stratification triglyceride levels
- global assessment risk stratification
- wide range triglyceride levels
- global assessment wide range
- risk stratification wide range
- disease events triglyceride levels
- disease events residual risk
- statin therapy triglyceride levels
- death in adults triglyceride levels
- residual risk triglyceride levels
- disease risk triglyceride levels
- statin use triglyceride levels